Cargando…

Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients

IMPORTANCE: Cardiovascular death remains the leading cause of mortality in patients with type 2 diabetes (T2D). A better understanding of the current use and adoption of glucose-lowering drugs with cardiovascular benefit can inform state policies to ensure their appropriate use in patients with T2D....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Mike Z., Avorn, Jerry, Liu, Jun, Kesselheim, Aaron S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644265/ https://www.ncbi.nlm.nih.gov/pubmed/36346634 http://dx.doi.org/10.1001/jamanetworkopen.2022.40117

Ejemplares similares

Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021
por: Roberts, Thomas J., et al.
Publicado: (2023)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

Differences in Diabetic Prescription Drug Utilization and Costs Among Patients With Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015
por: Khorrami, Peggah, et al.
Publicado: (2022)

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
por: Clemans-Cope, Lisa, et al.
Publicado: (2023)

Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)

Public sector financial support for late stage discovery of new drugs in the United States: cohort study
por: Nayak, Rahul K, et al.
Publicado: (2019)

Conflict of Interest Reporting by Authors Involved in Promotion of Off-Label Drug Use: An Analysis of Journal Disclosures
por: Kesselheim, Aaron S., et al.
Publicado: (2012)

Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit
por: Bendicksen, Liam, et al.
Publicado: (2022)

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
por: Sarpatwari, Ameet, et al.
Publicado: (2015)

Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic
por: Rome, Benjamin N., et al.
Publicado: (2021)

Public funding for transformative drugs: the case of sofosbuvir
por: Barenie, Rachel E., et al.
Publicado: (2021)

Clinicians’ Contributions to the Development of Coronary Artery Stents: A Qualitative Study of Transformative Device Innovation
por: Kesselheim, Aaron S., et al.
Publicado: (2014)

Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
por: Moneer, Osman, et al.
Publicado: (2021)

Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review
por: Austad, Kirsten E., et al.
Publicado: (2011)

The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs
por: Kesselheim, Aaron S., et al.
Publicado: (2012)

Health Care Use and Spending Among Need-Based Subgroups of Medicare Beneficiaries With Full Medicaid Benefits
por: Kaufman, Brystana G., et al.
Publicado: (2023)

Association of State Medicaid Expansion With Hospital Community Benefit Spending
por: Kanter, Genevieve P., et al.
Publicado: (2020)

Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov
por: Bothwell, Laura E, et al.
Publicado: (2018)

Association of Prenatal Care Expansion With Use of Antidiabetic Agents During Pregnancies Among Latina Emergency Medicaid Recipients With Gestational Diabetes
por: Rodriguez, Maria I., et al.
Publicado: (2022)

Medicaid prescription limits: policy trends and comparative impact on utilization
por: Lieberman, Daniel A., et al.
Publicado: (2016)

Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018
por: Cholera, Rushina, et al.
Publicado: (2021)

Medicaid Enrollment and Service Use Among Adults With Down Syndrome
por: Rubenstein, Eric, et al.
Publicado: (2023)

Geographical Variation in Health Spending Across the US Among Privately Insured Individuals and Enrollees in Medicaid and Medicare
por: Cooper, Zack, et al.
Publicado: (2022)

Association of Medicaid Expansion With Medicaid Enrollment and Health Care Use Among Older Adults With Low Income and Chronic Condition Limitations
por: McInerney, Melissa, et al.
Publicado: (2022)

Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
por: Skydel, Joshua J., et al.
Publicado: (2022)

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
por: Lindner, Stephan R., et al.
Publicado: (2023)

Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
por: Sachs, Rachel E., et al.
Publicado: (2021)

Analysis of Contraceptive Use Among Immigrant Women Following Expansion of Medicaid Coverage for Postpartum Care
por: Rodriguez, Maria I., et al.
Publicado: (2021)

Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study
por: Liu, Michael, et al.
Publicado: (2020)

Comparison of Postpartum Health Care Use and Spending Among Individuals with Medicaid-Paid Births Enrolled in Continuous Medicaid vs Commercial Insurance
por: Gordon, Sarah H., et al.
Publicado: (2022)

Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021
por: Shoulders, Angela, et al.
Publicado: (2023)

Association Between Medicaid Prescription Drug Limits and Access to Medications and Health Care Use Among Young Adults With Disabilities
por: Geiger, Caroline K., et al.
Publicado: (2021)

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
por: Cherla, Avi, et al.
Publicado: (2021)

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
por: D’Andrea, Elvira, et al.
Publicado: (2020)

Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval
por: Kesselheim, Aaron S., et al.
Publicado: (2016)

Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
por: D’Andrea, Elvira, et al.
Publicado: (2019)

Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021
por: Daval, C. Joseph Ross, et al.
Publicado: (2023)

Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use
por: Auty, Samantha G., et al.
Publicado: (2021)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Association of Medicaid Eligibility With Surgical Readmission Among Medicare Beneficiaries
por: Cher, Benjamin A. Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bu43kkjo1tj25248n8ekrld05h